Josephine Hirsch
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Josephine Hirsch has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
- Ilina Rosoklija
Clinical Research and Quality Improvement, Department of Surgery, Division of Pediatric Urology, Ann & Robert H. Lurie Children's Hospital, Chicago, IL, USA
6 shared publications - Earl Y. Cheng
Division of Urology, Ann & Robert Lurie Children’s Hospital of Chicago, Chicago, Illinois
5 shared publications - Elizabeth B. Yerkes
Division of Urology, Ann & Robert Lurie Children’s Hospital of Chicago, Chicago, Illinois
5 shared publications - David Chu
Division of Urology, Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, Illinois
4 shared publications - Diana K. Bowen
Division of Urology, Ann & Robert Lurie Children’s Hospital of Chicago, Chicago, Illinois
4 shared publications Elizabeth B. Yerkes
Division of Urology, Ann & Robert H. Lurie Children's Hospital of Chicago, 225 E Chicago Ave, Chicago, IL 60611, USA
4 shared publications
Latest Publications
- 1 November 2026
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 216 (5) , 724-731
Diagnostic Test Characteristics of Renal Ultrasound Findings for High-Risk Bladder in Spina Bifida
Spina bifida (SB) can cause neurogenic bladder dysfunction and renal deterioration. Guidelines recommend renal ultrasound (RUS) for surveillance, but its utility in screening for high-risk bladder is unclear. We evaluated the performance of RUS findings for detecting high-risk bladder in youth with SB. We conducted a retrospective cohort study of patients with myelomeningocele at a pediatric SB clinic who had a RUS within three months of urodynamic studies (UDS). RUS parameters included hydronephrosis, thinned parenchyma, hypoplasia, and scarring. High-risk bladder was defined as end-fill pressures/detrusor leak point pressures of 40 cmH2O or greater. We calculated sensitivity, specificity, and overall diagnostic accuracy (AUC) of RUS parameters for high-risk bladder, adjusting for repeat measurements. Various subgroup and sensitivity analyses were performed. We analyzed 575 UDS-RUS dyads from 244 unique patients. Median age was 7.2 years, 70% had ventricular shunts. 25% of dyads had high-risk bladder. Any hydronephrosis by Society for Fetal Urology (SFU) grading demonstrated an overall sensitivity 50%, specificity 57%, and clustered AUC of 55% for detecting high-risk bladder. RUS had similar performance across additional analyses, including non-ambulatory patients, high-grade hydronephrosis (SFU 3-4), any RUS abnormality, and using Urinary Tract Dilation (UTD) grading instead of SFU grading. Any hydronephrosis had higher test sensitivity for high-risk bladder in fuller bladders on RUS (RUS-bladder volume >75% of UDS-bladder capacity). RUS should not be used alone as a screening tool to identify high-risk bladder in youth with SB given its limited sensitivity and diagnostic utility. UDS remains an essential and necessary tool for surveilling at-risk bladders.
- 1 November 2026
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 216 (5) , 724-731
Diagnostic Test Characteristics of Renal Ultrasound Findings for High-Risk Bladder in Spina Bifida
Spina bifida (SB) can cause neurogenic bladder dysfunction and renal deterioration. Guidelines recommend renal ultrasound (RUS) for surveillance, but its utility in screening for high-risk bladder is unclear. We evaluated the performance of RUS findings for detecting high-risk bladder in youth with SB. We conducted a retrospective cohort study of patients with myelomeningocele at a pediatric SB clinic who had a RUS within three months of urodynamic studies (UDS). RUS parameters included hydronephrosis, thinned parenchyma, hypoplasia, and scarring. High-risk bladder was defined as end-fill pressures/detrusor leak point pressures of 40 cmH2O or greater. We calculated sensitivity, specificity, and overall diagnostic accuracy (AUC) of RUS parameters for high-risk bladder, adjusting for repeat measurements. Various subgroup and sensitivity analyses were performed. We analyzed 575 UDS-RUS dyads from 244 unique patients. Median age was 7.2 years, 70% had ventricular shunts. 25% of dyads had high-risk bladder. Any hydronephrosis by Society for Fetal Urology (SFU) grading demonstrated an overall sensitivity 50%, specificity 57%, and clustered AUC of 55% for detecting high-risk bladder. RUS had similar performance across additional analyses, including non-ambulatory patients, high-grade hydronephrosis (SFU 3-4), any RUS abnormality, and using Urinary Tract Dilation (UTD) grading instead of SFU grading. Any hydronephrosis had higher test sensitivity for high-risk bladder in fuller bladders on RUS (RUS-bladder volume >75% of UDS-bladder capacity). RUS should not be used alone as a screening tool to identify high-risk bladder in youth with SB given its limited sensitivity and diagnostic utility. UDS remains an essential and necessary tool for surveilling at-risk bladders.
- 6 October 2026
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 23 (1) , 106315
Constipation status and the enhanced recovery pathway in bladder reconstruction
- 6 October 2026
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 23 (1) , 106315
Constipation status and the enhanced recovery pathway in bladder reconstruction
- Open Access
- 16 July 2025
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 21 (6) , 1619-1629
Decision-making experiences in gonadectomy and gonadal tissue cryopreservation for adolescents/young adults and parents of individuals with differences of sex development: A qualitative study
- 16 July 2025
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 21 (6) , 1619-1629
Open AccessDecision-making experiences in gonadectomy and gonadal tissue cryopreservation for adolescents/young adults and parents of individuals with differences of sex development: A qualitative study
- Open Access
- 7 June 2025
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 60 (9) , 162400
Formal Fertility Preservation Program Facilitates Equitable Fertility Care Among Pediatric Oncology and Stem Cell Transplant Patients
- 7 June 2025
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 60 (9) , 162400
Open AccessFormal Fertility Preservation Program Facilitates Equitable Fertility Care Among Pediatric Oncology and Stem Cell Transplant Patients
- 26 April 2025
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 21 (5) , 1146-1153
Role of endocrine and genetic evaluation for infants with proximal hypospadias
- 26 April 2025
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 21 (5) , 1146-1153
Role of endocrine and genetic evaluation for infants with proximal hypospadias
- Open Access
Long-read sequencing resolves the clinically relevant CYP21A2 locus, supporting a new clinical test for Congenital Adrenal Hyperplasia
Congenital Adrenal Hyperplasia (CAH), one of the most common inherited disorders, is caused by defects in adrenal steroidogenesis. It is potentially lethal if untreated and is associated with multiple comorbidities, including fertility issues, obesity, insulin resistance, and dyslipidemia. CAH can result from variants in multiple genes, but the most frequent cause is deletions and conversions in the segmentally duplicated RCCX module, which contains the CYP21A2 gene and a pseudogene. The molecular genetic test to identify pathogenic alleles is cumbersome, incomplete, and available from a limited number of laboratories. It requires testing parents for accurate interpretation, leading to healthcare inequity. Less severe forms are frequently misdiagnosed, and phenotype/genotype correlations incompletely understood. We explored whether emerging technologies could be leveraged to identify all pathogenic alleles of CAH, including phasing in proband-only cases. We targeted long-read sequencing outputs that would be practical in a clinical laboratory setting. Both HiFi-based and nanopore-based whole-genome long-read sequencing datasets could be mined to accurately identify pathogenic single-nucleotide variants, full gene deletions, fusions creating non-functional hybrids between the gene and pseudogene (“30-kb deletion”), as well as count the number of RCCX modules and phase the resulting multimodular haplotypes. On the Hi-Fi data set of 6 samples, the PacBio Paraphase tool was able to distinguish nine different mono-, bi-, and tri-modular haplotypes, as well as the 30-kb and whole gene deletions. To do the same on the ONT-Nanopore dataset, we designed a tool, Parakit, which creates an enriched local pangenome to represent known haplotype assemblies and map ClinVar pathogenic variants and fusions onto them. With few labels in the region, optical genome mapping was not able to reliably resolve module counts or fusions, although designing a tool to mine the dataset specifically for this region may allow doing so in the future. Both sequencing techniques yielded congruent results, matching clinically identified variants, and offered additional information above the clinical test, including phasing, count of RCCX modules, and status of the other module genes, all of which may be of clinical relevance. Thus long-read sequencing could be used to identify variants causing multiple forms of CAH in a single test.
Open AccessLong-read sequencing resolves the clinically relevant CYP21A2 locus, supporting a new clinical test for Congenital Adrenal Hyperplasia
Congenital Adrenal Hyperplasia (CAH), one of the most common inherited disorders, is caused by defects in adrenal steroidogenesis. It is potentially lethal if untreated and is associated with multiple comorbidities, including fertility issues, obesity, insulin resistance, and dyslipidemia. CAH can result from variants in multiple genes, but the most frequent cause is deletions and conversions in the segmentally duplicated RCCX module, which contains the CYP21A2 gene and a pseudogene. The molecular genetic test to identify pathogenic alleles is cumbersome, incomplete, and available from a limited number of laboratories. It requires testing parents for accurate interpretation, leading to healthcare inequity. Less severe forms are frequently misdiagnosed, and phenotype/genotype correlations incompletely understood. We explored whether emerging technologies could be leveraged to identify all pathogenic alleles of CAH, including phasing in proband-only cases. We targeted long-read sequencing outputs that would be practical in a clinical laboratory setting. Both HiFi-based and nanopore-based whole-genome long-read sequencing datasets could be mined to accurately identify pathogenic single-nucleotide variants, full gene deletions, fusions creating non-functional hybrids between the gene and pseudogene (“30-kb deletion”), as well as count the number of RCCX modules and phase the resulting multimodular haplotypes. On the Hi-Fi data set of 6 samples, the PacBio Paraphase tool was able to distinguish nine different mono-, bi-, and tri-modular haplotypes, as well as the 30-kb and whole gene deletions. To do the same on the ONT-Nanopore dataset, we designed a tool, Parakit, which creates an enriched local pangenome to represent known haplotype assemblies and map ClinVar pathogenic variants and fusions onto them. With few labels in the region, optical genome mapping was not able to reliably resolve module counts or fusions, although designing a tool to mine the dataset specifically for this region may allow doing so in the future. Both sequencing techniques yielded congruent results, matching clinically identified variants, and offered additional information above the clinical test, including phasing, count of RCCX modules, and status of the other module genes, all of which may be of clinical relevance. Thus long-read sequencing could be used to identify variants causing multiple forms of CAH in a single test.
- 6 December 2024
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 21 (2) , 420-425
Continent catheterizable channels: Does “hitching” the bladder reduce complications?
- 6 December 2024
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 21 (2) , 420-425
Continent catheterizable channels: Does “hitching” the bladder reduce complications?
- 1 August 2024
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 212 (2) , 362-371
Quality of Life and Bladder Symptoms in Adolescents and Young Adults With Spina Bifida Who Catheterize via Urethra vs Catheterizable Channel
To assess associations between health-related quality of life (HRQOL), bladder-related QOL, bladder symptoms, and bladder catheterization route among adolescents and young adults (AYA) with spina bifida (SB). Clinical questionnaires administered to individuals ≥ 12-years-old requiring catheterization between June 2019-March 2020 in a SB center were retrospectively analyzed. Questionnaires were completed in English or Spanish independently or with caregiver assistance. Medical records were reviewed for demographic and clinical characteristics. Primary exposure was catheterization route (urethra or channel). Primary outcome was HRQOL, measured by Patient Reported Outcome Measure Information System Pediatric Global Health 7 (PGH-7). Secondary outcomes were bladder-related QOL and bladder symptoms, measured by Neurogenic Bladder Symptom Score (NBSS). Nested, multivariable linear regression models assessed associations between catheterization route and questionnaire scores. Of 162 patients requiring catheterization, 146 completed both the PGH-7 and NBSS and were included. Seventy-three percent catheterized via urethra and 27% via channel. Median age was 17.5 years (range 12-31), 58% of patients were female, and 80% had myelomeningocele. Urinary incontinence was more common among those who catheterized via urethra (60%) compared to channel (33%). On adjusted analyses, catheterization route was not significantly associated with PGH-7 or NBSS bladder-related QOL scores. More bladder symptoms were associated with worse bladder-related QOL. Patients who catheterized via channel had fewer bladder symptoms than those who catheterized via urethra. Catheterization route was not significantly associated with QOL. Though catheterization via channel was associated with fewer bladder symptoms, only degree of current bladder symptoms was significantly associated with bladder-related QOL.
- 1 August 2024
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 212 (2) , 362-371
Quality of Life and Bladder Symptoms in Adolescents and Young Adults With Spina Bifida Who Catheterize via Urethra vs Catheterizable Channel
To assess associations between health-related quality of life (HRQOL), bladder-related QOL, bladder symptoms, and bladder catheterization route among adolescents and young adults (AYA) with spina bifida (SB). Clinical questionnaires administered to individuals ≥ 12-years-old requiring catheterization between June 2019-March 2020 in a SB center were retrospectively analyzed. Questionnaires were completed in English or Spanish independently or with caregiver assistance. Medical records were reviewed for demographic and clinical characteristics. Primary exposure was catheterization route (urethra or channel). Primary outcome was HRQOL, measured by Patient Reported Outcome Measure Information System Pediatric Global Health 7 (PGH-7). Secondary outcomes were bladder-related QOL and bladder symptoms, measured by Neurogenic Bladder Symptom Score (NBSS). Nested, multivariable linear regression models assessed associations between catheterization route and questionnaire scores. Of 162 patients requiring catheterization, 146 completed both the PGH-7 and NBSS and were included. Seventy-three percent catheterized via urethra and 27% via channel. Median age was 17.5 years (range 12-31), 58% of patients were female, and 80% had myelomeningocele. Urinary incontinence was more common among those who catheterized via urethra (60%) compared to channel (33%). On adjusted analyses, catheterization route was not significantly associated with PGH-7 or NBSS bladder-related QOL scores. More bladder symptoms were associated with worse bladder-related QOL. Patients who catheterized via channel had fewer bladder symptoms than those who catheterized via urethra. Catheterization route was not significantly associated with QOL. Though catheterization via channel was associated with fewer bladder symptoms, only degree of current bladder symptoms was significantly associated with bladder-related QOL.
- 21 May 2022
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 18 (4) , 491.e1-491.e9
Attitudes toward fertility-related care and education of adolescents and young adults with differences of sex development: Informing future care models
- 21 May 2022
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 18 (4) , 491.e1-491.e9
Attitudes toward fertility-related care and education of adolescents and young adults with differences of sex development: Informing future care models